Chiara Crotti

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Top Venues

Therapeutic advances in musculoskeletal disease

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Orsini, Chiara Crotti, Gilberto Cincinelli, Raffaele Di Taranto, Andrea Amati, Matteo Ferrito, Massimo Varenna, Roberto Caporali
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review. Biology 12 (10) (2023)
Angelo Fassio, Fabiola Atzeni, Maurizio Rossini, Valeria D'Amico, Francesco Paolo Cantatore, Maria Sole Chimenti, Chiara Crotti, Bruno Frediani, Andrea Giusti, Giusy Peluso, Guido Rovera, Palma Scolieri, Vincenzo Raimondo, Davide Gatti, null On Behalf Of The Study Group On Osteoporosis And Skeletal Metabolic Diseases Of The Italian Society Of Rheumatology
Osteoimmunology of Spondyloarthritis. International journal of molecular sciences 24 (19) (2023)
Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Therapeutic advances in musculoskeletal disease 14 (2022)
Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Therapeutic advances in musculoskeletal disease 14 (2022)
Massimo Varenna, Vania Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. Therapeutic advances in musculoskeletal disease 13 (2021)